Draft Genome Sequence of Streptomyces rapamycinicus Strain NRRL 5491, the Producer of the Immunosuppressant Rapamycin

Streptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.

Detalles Bibliográficos
Autores principales: Baranasic, Damir, Gacesa, Ranko, Starcevic, Antonio, Zucko, Jurica, Blažič, Marko, Horvat, Marinka, Gjuračić, Krešimir, Fujs, Štefan, Hranueli, Daslav, Kosec, Gregor, Cullum, John, Petković, Hrvoje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2013
Materias:
Prokaryotes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738893/
https://www.ncbi.nlm.nih.gov/pubmed/23929477
http://dx.doi.org/10.1128/genomeA.00581-13
Descripción
Sumario:Streptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.

Ejemplares similares